Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xueliang Fang

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|October 3, 2003
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approachJudith Varady, Xihan Wu, Xueliang Fang, et al.
IET Nanobiotechnology|August 11, 2018
Biosynthesis of AgNPs by <i>B. maydis</i> and its antifungal effect against <i>Exserohilum turcicum</i>Weidong Huang, Xueliang Fang, Hongdao Wang, et al.
International Journal of Molecular Sciences|April 12, 2022
<i>OsSPLs</i> Regulate Male Fertility in Response to Different Temperatures by Flavonoid Biosynthesis and Tapetum PCD in PTGMS RiceYujun Sun, Ming Fu, Lei Wang, et al.
Journal of Medicinal Chemistry|June 23, 2006
Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategyYipin Lu, Zaneta Nikolovska-Coleska, Xueliang Fang, et al.
Frontiers in Immunology|September 26, 2022
Non-coding RNA-mediated high expression of <i>SFXN3</i> as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancerKailin Chen, Sha Gong, Xueliang Fang, et al.
Cancer Letters|February 13, 2007
Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cellsManchao Zhang, Xueliang Fang, Hongpeng Liu, et al.
Analytical Biochemistry|August 25, 2004
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarizationZaneta Nikolovska-Coleska, Renxiao Wang, Xueliang Fang, et al.
Environmental Science and Pollution Research International|August 30, 2023
Energy-economy-environment assessments of refrigerants R152a and R134a in a vapor compression refrigeration system using a variable displacement oil-free linear compressorXueliang Fang, Meng-Choung Chiong, Xinyue Jiang, et al.
Journal of Medicinal Chemistry|June 9, 2012
Correction to Design of Bcl-2 and Bcl-xL Inhibitors with Subnanomolar Binding Affinities Based upon a New ScaffoldHaibin Zhou, Jianfang Chen, Jennifer L Meagher, et al.
Journal of Medicinal Chemistry|March 28, 2012
Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffoldHaibin Zhou, Jianfang Chen, Jennifer L Meagher, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|October 3, 2003
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approachJudith Varady, Xihan Wu, Xueliang Fang, et al.
IET Nanobiotechnology|August 11, 2018
Biosynthesis of AgNPs by <i>B. maydis</i> and its antifungal effect against <i>Exserohilum turcicum</i>Weidong Huang, Xueliang Fang, Hongdao Wang, et al.
International Journal of Molecular Sciences|April 12, 2022
<i>OsSPLs</i> Regulate Male Fertility in Response to Different Temperatures by Flavonoid Biosynthesis and Tapetum PCD in PTGMS RiceYujun Sun, Ming Fu, Lei Wang, et al.
Journal of Medicinal Chemistry|June 23, 2006
Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategyYipin Lu, Zaneta Nikolovska-Coleska, Xueliang Fang, et al.
Frontiers in Immunology|September 26, 2022
Non-coding RNA-mediated high expression of <i>SFXN3</i> as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancerKailin Chen, Sha Gong, Xueliang Fang, et al.
Cancer Letters|February 13, 2007
Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cellsManchao Zhang, Xueliang Fang, Hongpeng Liu, et al.
Analytical Biochemistry|August 25, 2004
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarizationZaneta Nikolovska-Coleska, Renxiao Wang, Xueliang Fang, et al.
Environmental Science and Pollution Research International|August 30, 2023
Energy-economy-environment assessments of refrigerants R152a and R134a in a vapor compression refrigeration system using a variable displacement oil-free linear compressorXueliang Fang, Meng-Choung Chiong, Xinyue Jiang, et al.
Journal of Medicinal Chemistry|June 9, 2012
Correction to Design of Bcl-2 and Bcl-xL Inhibitors with Subnanomolar Binding Affinities Based upon a New ScaffoldHaibin Zhou, Jianfang Chen, Jennifer L Meagher, et al.
Journal of Medicinal Chemistry|March 28, 2012
Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffoldHaibin Zhou, Jianfang Chen, Jennifer L Meagher, et al.
Pageof 3